SCHEMBL29366803

SCHEMBL29366803

Cc1c(C)c([N+](=O)[O-])c(Br)c(C)c1[N+](=O)[O-]

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.42
▸ TDP1 Q9NUW8 4/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ GRIN2D O15399 3/20 0.37
▸ GRIN3B O60391 3/20 0.37
▸ GRIN1 Q05586 3/20 0.37
▸ GRIN2A Q12879 3/20 0.37
▸ GRIN2B Q13224 3/20 0.37
▸ GRIN2C Q14957 3/20 0.37
▸ GRIN3A Q8TCU5 3/20 0.37
▸ TSHR P16473 5/20 0.34
▸ PKM P14618 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ MAPT P10636 2/20 0.31
▸ ACHE P22303 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16201559 0.90 CYP1A2 (0.42) CYP1A2TDP1ALDH1A1GRIN2DGRIN3B
SCHEMBL15357212 0.88 CYP1A2 (0.45) CYP1A2TDP1ALDH1A1GRIN2DGRIN3B
SCHEMBL9168661 0.87 CYP1A2 (0.48) CYP1A2TDP1ALDH1A1GRIN2DGRIN3B
SCHEMBL25212337 0.87 CYP1A2 (0.48) CYP1A2TDP1ALDH1A1GRIN2DGRIN3B
SCHEMBL8990388 0.87 CYP1A2 (0.48) CYP1A2TDP1ALDH1A1GRIN2DGRIN3B
SCHEMBL15357214 0.85 CYP1A2 (0.47) CYP1A2TDP1ALDH1A1GRIN2DGRIN3B
SCHEMBL7592620 0.84 TDP1 (0.50) CYP1A2TDP1ALDH1A1GRIN2DGRIN3B
SCHEMBL3816541 0.81 TDP1 (0.48) CYP1A2TDP1ALDH1A1GRIN2DGRIN3B
SCHEMBL4927428 0.78 TDP1 (0.50) CYP1A2TDP1ALDH1A1GRIN2DGRIN3B
SCHEMBL5160819 0.78 CYP1A2 (0.37) CYP1A2TDP1ALDH1A1GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113993872-B EGFR inhibitors for the treatment of cancer 豪夫迈·罗氏有限公司 2024-09-24 — — CN disclosed
CN-113993872-A EGFR inhibitors for the treatment of cancer 豪夫迈·罗氏有限公司 2022-01-28 — — CN disclosed
Send feedback